Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0N9KZ
|
|||
| Former ID |
DIB001206
|
|||
| Drug Name |
TN-871
|
|||
| Synonyms |
1-[6-Butyl-5H-indeno[5,6-d]-1,3-dioxol-5-yl]-4-methylpiperazine dihydrochloride; 2-n-Butyl-5,6-methylenedioxy-1-(4-methylpiperazinyl)indene dihydrochloride
Click to Show/Hide
|
|||
| Indication | Cognitive impairment [ICD-11: 6D71; ICD-10: F06.7] | Phase 2 | [1] | |
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Neurotransmitter release (NT rele) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001383) | |||
| REF 2 | Effects of an indene-derivative, TN-871, on synaptic transmission in a sympathetic ganglion: presynaptic actions on neurotransmitter release. Bull Tokyo Med Dent Univ. 1995 Mar;42(1):19-29. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.